Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Investing

Pfizer : PFE

All Pfizer Articles

1501 Articles

Paul Ausick | Nov 24, 2015 at 4:01 PM EST

The 4 Stocks That Buoyed the DJIA on Tuesday

November 24, 2015: Markets opened lower on Tuesday following reports that a Turkish plane had shot down a Russian plane…

Lee Jackson | Nov 24, 2015 at 10:47 AM EST

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

Despite the howling from political candidates trying to make the top drug-makers their whipping boy in populist campaign efforts, the…

Paul Ausick | Nov 23, 2015 at 4:01 PM EST

The 4 Stocks That Weighed on the Dow Monday

November 23, 2015: Markets opened mixed on Monday with very slight positive or negative differences from Friday’s closing prices. The…

Lee Jackson | Nov 20, 2015 at 9:35 AM EST

4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming

A new Jefferies research report highlights four top companies that could be looking at catalysts that in the very near…

Chris Lange | Nov 18, 2015 at 9:10 AM EST

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Jefferies has updated the thesis behind its "Top 5 for 2015" pharmaceutical stock picks

Chris Lange | Nov 11, 2015 at 8:15 AM EST

Short Sellers Continue to Decrease Bets in Major Pharma

The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical…

Paul Ausick | Nov 4, 2015 at 4:01 PM EST

The 4 Stocks Held Down the DJIA on Wednesday

November 4, 2015: Markets opened higher on Wednesday following an in-line report on jobs from ADP and somewhat smaller-than-expected U.S.…

Lee Jackson | Nov 4, 2015 at 10:40 AM EST

UBS Has 4 Safe Blue Chip Dividends to Buy, Even If the Market Has Topped

Solid growth stocks that pay good dividends make sense, especially when they all pay higher dividends than the current 30-year…

Chris Lange | Nov 3, 2015 at 11:45 AM EST

Why 2 Analysts Are Talking Up a Pfizer-Allergan Merger

The health care sector may have sold off a fair amount since this past summer, but there is some M&A…

Paul Ausick | Nov 2, 2015 at 4:01 PM EST

The 4 Stocks Lifted the DJIA on Monday

November 2, 2015: Markets opened higher on Monday and added strength as the day drew to a close. Healthcare and…

Chris Lange | Oct 31, 2015 at 10:10 AM EDT

6 BioPharma Movers That Cannot Be Ignored

Last week, a few biotech companies made absolutely massive runs, and some had serious falls.

Paul Ausick | Oct 30, 2015 at 4:01 PM EDT

The 4 Stocks That Sank the Dow on Friday

October 30, 2015: Markets opened higher on Friday before falling into the red until the early afternoon. Financial stocks could…

Paul Ausick | Oct 29, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA Thursday

ThinkstockOctober 29, 2015: Markets opened lower on Thursday after a GDP report that was a bit softer than expected and…

Jon C. Ogg | Oct 29, 2015 at 11:05 AM EDT

What a Combined Allergan and Pfizer Might Actually Look Like

Allergan has issued a press release that confirms some of the rumors floating in the market that it has been…

Jon C. Ogg | Oct 27, 2015 at 10:05 AM EDT

How Pfizer Stacks Up Against Merck on Earnings

Pfizer and Merck both released their third-quarter earnings on Tuesday morning. So, which drug giant is looking better after earnings?

1 … 56 57 58 59 60 … 101

Pfizer : PFE

All Pfizer Articles

The 4 Stocks That Buoyed the DJIA on Tuesday

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

The 4 Stocks That Weighed on the Dow Monday

4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Short Sellers Continue to Decrease Bets in Major Pharma

The 4 Stocks Held Down the DJIA on Wednesday

UBS Has 4 Safe Blue Chip Dividends to Buy, Even If the Market Has Topped

Why 2 Analysts Are Talking Up a Pfizer-Allergan Merger

The 4 Stocks Lifted the DJIA on Monday

6 BioPharma Movers That Cannot Be Ignored

The 4 Stocks That Sank the Dow on Friday

The 4 Stocks That Weighed on the DJIA Thursday

What a Combined Allergan and Pfizer Might Actually Look Like

How Pfizer Stacks Up Against Merck on Earnings

Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

What Would Steve Jobs Do Today?

Is This Where AMD Catches Nvidia? Goldman Sachs Says It’s Gaining Ground

3 Pipeline Stocks Paying You to Wait in July

Slow Mornings on the French Riviera: Retire to the South of France at 62 on $1.1 Million

$1 Million Annuity Locks In $6,100 a Month for Life, but What Happens to Surviving Spouse?

What Would Steve Jobs Do Today?

Is This Where AMD Catches Nvidia? Goldman Sachs Says It’s Gaining Ground

Pfizer : PFE

All Pfizer Articles

The 4 Stocks That Buoyed the DJIA on Tuesday

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

The 4 Stocks That Weighed on the Dow Monday

4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Short Sellers Continue to Decrease Bets in Major Pharma

The 4 Stocks Held Down the DJIA on Wednesday

UBS Has 4 Safe Blue Chip Dividends to Buy, Even If the Market Has Topped

Why 2 Analysts Are Talking Up a Pfizer-Allergan Merger

The 4 Stocks Lifted the DJIA on Monday

6 BioPharma Movers That Cannot Be Ignored

The 4 Stocks That Sank the Dow on Friday

The 4 Stocks That Weighed on the DJIA Thursday

What a Combined Allergan and Pfizer Might Actually Look Like

How Pfizer Stacks Up Against Merck on Earnings

Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

What Would Steve Jobs Do Today?

Is This Where AMD Catches Nvidia? Goldman Sachs Says It’s Gaining Ground

3 Pipeline Stocks Paying You to Wait in July

Featured Reads

Slow Mornings on the French Riviera: Retire to the South of France at 62 on $1.1 Million

$1 Million Annuity Locks In $6,100 a Month for Life, but What Happens to Surviving Spouse?